Efficacy and safety of olmesartan medoxomil‑amlodipine besylate tablets (Sevikar<sup>®</sup>) in older patients with essential hypertension: Subgroup analysis from the Sevikar study.
Journal Information
Full Title: Exp Ther Med
Abbreviation: Exp Ther Med
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Medicine, Research & Experimental
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Competing interests JD, LW and MLi are employees of Daiichi Sankyo (China) Holdings Co., Ltd., the company that makes SVK. The other authors declare that they have no competing interests."
"Funding: The present study was supported by Daiichi Sankyo (China) Holdings Co., Ltd, Shanghai, China."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025